Deep Apple Therapeutics

In a vast, unexplored virtual chemical space, Deep Apple Therapeutics moves with unprecedented speed to discover novel small molecules for high-value targets. Deep Apple combines ensemble cryo-EM to explore receptor conformations; deep learning; and the docking of multi-billion compound libraries generated using the companys proprietary Orchard.aiTM algorithm. Deep Apples deep learning discovery engine is built upon founder expertise in computational modeling, protein and target structure determination, large-scale molecular docking, and the elucidation of protein dynamics and conformational transitions. This structure-based, machine-learning driven drug design approach enables the company to rapidly advance novel candidates addressing well-validated targets in inflammatory, metabolic, and...

Drug discovery,deep learning,ai,large-scale docking,structural biology,machine learning,drug development,and biotechnology

Deep apple therapeutics operates in the Biotechnology research industry.

Deep apple therapeutics's revenue is 11m - 100m

Deep apple therapeutics has 11 - 50 employees.